Register for email alerts and news feeds:
This journal | BMJ Group
rss
British Journal of Ophthalmology 2004;88:603-604; doi:10.1136/bjo.2003.040022
Copyright © 2004 by the BMJ Publishing Group Ltd.
British Journal of Ophthalmology 2004;88:603-604
© 2004 BMJ Publishing Group Ltd

EDITORIAL

Dry eyes

The treatment of dry eyes

J P Whitcher

Correspondence to:
Correspondence to:
J P Whitcher
University of California San Francisco, 95 Kirkham Street, San Francisco, CA 94143-0944, USA; Nepal@itsa.ucsf.edu


To know it is still not to love it

Keywords: autologous serum; ocular surface disease; dry eye; keratoconjunctivitis sicca

The first 150 words of the full text of this article appear below.

The dry eye is often referred to as a condition, a syndrome, or a disease; and it is likewise known by a variety of terms. Keratoconjunctivitis sicca (KCS), or more commonly keratitis sicca, refers to any eye with some degree of dryness either by history or by objective clinical findings. The literature is confusing on this subject and often blurs the difference between the symptoms of dryness and clinical findings based on objective criteria.1 In similar fashion, the term dry eye syndrome is sometimes used interchangeably with dry eye symptoms, a lapse in descriptive terminology that unfortunately clouds the issue. Other descriptive terms for ocular dryness include xerophthalmia, which is used almost exclusively to describe the eye findings associated with vitamin A deficiency in children, and xerosis, which connotes the extreme ocular dryness and keratinisation that sometimes occurs after Stevens-Johnson syndrome, trachoma, and other causes of severe conjunctival . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease
B A Noble, R S K Loh, S MacLennan, K Pesudovs, A Reynolds, L R Bridges, J Burr, O Stewart, and S Quereshi
Br. J. Ophthalmol. 2004 88: 647-652. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Geerling, G, MacLennan, S, Hartwig, D (2004). Autologous serum eye drops for ocular surface disorders. Br. J. Ophthalmol. 88: 1467-1474 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Ophthalmology Jobs

Ophthalmology Jobs